Literature DB >> 1688526

Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.

V Gross1, J Schölmerich, H G Leser, R Salm, M Lausen, K Rückauer, U Schöffel, L Lay, A Heinisch, E H Farthmann.   

Abstract

Complexes of granulocyte elastase and alpha 1-antitrypsin are markers for granulocyte activation. In 75 patients with acute pancreatitis these complexes were immunologically determined daily in plasma during the first week of hospitalization. Patients were classified into three groups: mild pancreatitis (I, less than or equal to 1 complication, N = 34), severe pancreatitis (II, greater than or equal to 2 complications, N = 29), lethal outcome (III, N = 12). Initially, granulocyte elastase (mean +/- SEM) was lower in group I (348 +/- 39 micrograms/liter) as compared to groups II (897 +/- 183 micrograms/l) and III (799 +/- 244 micrograms/liter), P less than 0.001 for I vs II + III. Initial elastase concentrations greater than 400 micrograms/liter were consistent with a severe or fatal course of the disease but did not distinguish between severe and lethal pancreatitis. In patients with mild or severe disease, mean elastase concentrations decreased continuously during the following days (197 +/- 15 micrograms/liter in mild cases, 325 +/- 30 micrograms/liter in severe cases at day 7). In patients with lethal disease, however, mean elastase concentrations even increased at day 2 and remained higher than 700 micrograms/liter during the observation period. At days 1 and 2 the predictive value for severe or lethal disease of raised (greater than 400 micrograms/liter) elastase concentrations [positive predictive value (PPV) 82%, negative predictive value (NPV) 81%] was better than that of elevated (greater than 100 mg/liter) C-reactive protein (PPV 73%, NPV 73%), elevated (greater than 4.0 g/liter) alpha 1-antitrypsin (PPV 59%, NPV 50%), or decreased (less than 1.5 g/liter) alpha 2-macroglobulin (PPV 82%, NPV 67%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688526     DOI: 10.1007/bf01537230

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

1.  Fatal pancreatitis, a consequence of excessive leukocyte stimulation?

Authors:  H Rinderknecht
Journal:  Int J Pancreatol       Date:  1988-03

2.  Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines.

Authors:  F Van Leuven; J J Cassiman; H Van Den Berghe
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.

Authors:  A Ray; S B Tatter; L T May; P B Sehgal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages.

Authors:  J Bauer; U Ganter; T Geiger; U Jacobshagen; T Hirano; T Matsuda; T Kishimoto; T Andus; G Acs; W Gerok
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

5.  Early diagnosis of pancreatic infection by computed tomography-guided aspiration.

Authors:  S G Gerzof; P A Banks; A H Robbins; W C Johnson; S J Spechler; S M Wetzner; J M Snider; R E Langevin; M E Jay
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

6.  Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.

Authors:  G Balldin; A Eddeland; K Ohlsson
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

7.  Elastase-alpha 1-proteinase inhibitor: an early indicator of septicemia and bacterial meningitis in children.

Authors:  C P Speer; M Rethwilm; M Gahr
Journal:  J Pediatr       Date:  1987-11       Impact factor: 4.406

8.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells.

Authors:  H Baumann; V Onorato; J Gauldie; G P Jahreis
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

10.  Changes in the kallikrein kinin system during acute pancreatitis in man.

Authors:  A Lasson; K Ohlsson
Journal:  Thromb Res       Date:  1984-07-01       Impact factor: 3.944

View more
  28 in total

1.  Assessment of severity of acute pancreatitis: a comparison between old and most recent modalities used to evaluate this perennial problem.

Authors:  Raffaele Pezzilli; Francesco Mancini
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.

Authors:  A R Exley; T Leese; M P Holliday; R A Swann; J Cohen
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

3.  Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

Authors:  S Tenner; C Fernandez-del Castillo; A Warshaw; W Steinberg; J Hermon-Taylor; J E Valenzuela; M Hariri; M Hughes; P A Banks
Journal:  Int J Pancreatol       Date:  1997-04

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis.

Authors:  M Oezcueruemez-Porsch; D Kunz; P D Hardt; T Fadgyas; O Kress; H U Schulz; H Schnell-Kretschmer; H Temme; S Westphal; C Luley; H U Kloer
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

6.  Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.

Authors:  J A Rivera; J Werner; A L Warshaw; K B Lewandrowski; D W Rattner; C Fernández del Castillo
Journal:  Int J Pancreatol       Date:  1998-04

Review 7.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Is obesity a significant prognostic factor in acute pancreatitis?

Authors:  C J Tsai
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

Review 9.  Acute biliary pancreatitis: diagnosis and treatment.

Authors:  Zakaria M Hazem
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

10.  JPN Guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis.

Authors:  Masahiko Hirota; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Miho Sekimoto; Yasutoshi Kimura; Kazunori Takeda; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.